173841-06-0 Usage
General Description
Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate is a chemical compound with the molecular formula C6H7ClN2O2. It is a pyrazole derivative with a chlorine atom and a methyl group attached to the pyrazole ring. Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It can also be used as a building block in organic synthesis to create various other compounds. Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate has potential applications in the field of medicinal chemistry and drug development due to its structural features and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 173841-06-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,8,4 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 173841-06:
(8*1)+(7*7)+(6*3)+(5*8)+(4*4)+(3*1)+(2*0)+(1*6)=140
140 % 10 = 0
So 173841-06-0 is a valid CAS Registry Number.
173841-06-0Relevant articles and documents
Sulfamide-aryl amide type compound and medical application thereof in treatment of hepatitis B
-
Paragraph 0312; 0313; 0317-0319, (2018/07/30)
The invention relates to a sulfamide-aryl amide type compound and the medical application thereof in treatment of hepatitis B, and specifically discloses a compound which can be treated as an HBV compound inhibitor and has the structure as shown in chemical formula (A), or a stereisomer, a cis-trans-isomer or a tautomer thereof, or pharmaceutically acceptable salt, aquo-complex or solvent compoundthereof; the identification of each group is shown in the description. The invention also relates to a medical composition containing the abovementioned compound and application thereof in treatmentof hepatitis B.
DISUBSTITUTED HETEROARYL-FUSED PYRIDINES
-
Page/Page column 52, (2012/10/18)
The invention relates to compound of the formula (I′) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
